RedHill Biopharma (RDHL) EBITDA Margin Growth (5y) (2017 - 2023)
RedHill Biopharma (RDHL) EBITDA Margin Growth (5y) (2017 - 2023) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - |
| 10 | RedHill Biopharma | 2.05 Bn | 2.05 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2023 | 258,619.00 |
| Mar 31, 2023 | -121,680.00 |
| Dec 31, 2022 | -130,975.00 |
| Sep 30, 2022 | -87,644.00 |
| Jun 30, 2022 | -275,318.00 |
| Mar 31, 2022 | 20.22 Mn |
| Dec 31, 2021 | -963,343.00 |
| Dec 31, 2020 | -957,245.00 |
| Jun 30, 2020 | -58.89 Mn |
| Dec 31, 2019 | -48.07 Mn |
| Sep 30, 2019 | 63,119.00 |
| Jun 30, 2019 | 79,196.00 |
| Mar 31, 2019 | -4.70 Bn |
| Dec 31, 2018 | -34.73 Mn |
| Sep 30, 2018 | 9.21 Mn |
| Jun 30, 2018 | 6.36 Mn |
| Dec 31, 2017 | 5.36 Mn |
| Sep 30, 2017 | 6.51 Mn |
| Jun 30, 2017 | -3.85 Mn |